ClinVar Miner

Submissions for variant NM_002764.4(PRPS1):c.477C>T (p.Ile159=)

gnomAD frequency: 0.00596  dbSNP: rs61752962
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 16
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000080032 SCV000111926 benign not specified 2014-02-19 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000080032 SCV000199989 benign not specified 2012-05-07 criteria provided, single submitter clinical testing "Ile159Ile in Exon 04 of PRPS1: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 0.8% (42/5545) of Eu ropean American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs61752962)."
Invitae RCV000204144 SCV000262494 benign Charcot-Marie-Tooth Neuropathy X 2024-02-01 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000080032 SCV000309180 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000362584 SCV000481430 benign Hearing loss, X-linked 1 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Illumina Laboratory Services, Illumina RCV000402522 SCV000481431 benign Phosphoribosylpyrophosphate synthetase superactivity 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Illumina Laboratory Services, Illumina RCV000308646 SCV000481432 benign Arts syndrome 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
GeneDx RCV001664331 SCV001874703 benign not provided 2015-03-03 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000308646 SCV002031950 benign Arts syndrome 2021-10-25 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001789127 SCV002031951 benign Charcot-Marie-Tooth disease X-linked recessive 5 2021-10-25 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000362584 SCV002031953 benign Hearing loss, X-linked 1 2021-10-25 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000402522 SCV002031954 benign Phosphoribosylpyrophosphate synthetase superactivity 2021-10-25 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002498407 SCV002805045 likely benign Arts syndrome; Hearing loss, X-linked 1; Charcot-Marie-Tooth disease X-linked recessive 5; Phosphoribosylpyrophosphate synthetase superactivity 2021-07-21 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001664331 SCV003799602 benign not provided 2023-10-18 criteria provided, single submitter clinical testing
Clinical Genetics, Academic Medical Center RCV000080032 SCV001918956 benign not specified no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV001664331 SCV001963181 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.